Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

PROMACTA、eltrombopag

Indications for the treatment of chronic immune (idiopathic) thrombocytopenia in children aged 6-11 years who have previously had poor response to glucocorticoids, immunoglobulins, etc.

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.